Journal for ImmunoTherapy of Cancer (Jun 2020)
Correction: Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Jun 2020)